How to transfer my Topamax prescription to Florida

If you’re struggling with Binge Eating Disorder (BED) and wondering whether you can access treatment through telehealth, the answer is increasingly yes—and the legal landscape in 2025-2026 makes it easier than ever. From federal regulatory extensions to state-specific rules, understanding where and how you can receive care remotely is crucial to getting the help you need.

This comprehensive guide walks through everything you need to know about accessing BED medications like Topamax (topiramate) and Wellbutrin (bupropion) via telehealth, including federal regulations, state requirements, provider types, safety considerations, and what to expect during your virtual visit.

Understanding Binge Eating Disorder and Treatment Options

Binge Eating Disorder is the most common eating disorder in the United States, characterized by recurrent episodes of eating large quantities of food, often quickly and to the point of discomfort. According to DSM-5 criteria, BED involves eating an unusually large amount within a two-hour period at least once weekly for three months, accompanied by a sense of lack of control and marked distress—without the compensatory purging behaviors seen in bulimia.

While cognitive behavioral therapy (CBT) remains the gold-standard treatment for BED, medication can play an important supportive role. The FDA has approved Vyvanse (lisdexamfetamine) specifically for BED, but as a controlled stimulant, it faces stricter telehealth prescribing rules. This has led many providers to focus on off-label medications that show clinical promise and can be prescribed more readily via telehealth:

• Topiramate (Topamax): Originally approved for seizures and migraines, topiramate has demonstrated effectiveness in reducing binge frequency and supporting weight management in some patients.
• Bupropion (Wellbutrin): An antidepressant and smoking cessation aid, bupropion can help address the mood and impulse-control aspects often associated with binge eating.

Both medications are non-controlled substances, which significantly simplifies telehealth access.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Regulations: What You Need to Know

The Ryan Haight Act and Non-Controlled Medications

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires an in-person medical evaluation before a controlled substance can be prescribed via telemedicine. However—and this is critical—this requirement does not apply to non-controlled medications like topiramate or bupropion.

Since the beginning of the COVID-19 pandemic, the DEA has extended special flexibilities for telehealth prescribing of controlled substances. As of January 2026, these flexibilities have been extended through December 31, 2026, meaning patients can still access certain controlled medications via telehealth while permanent rules are being finalized.

For non-controlled BED medications, there has never been a federal in-person requirement. This means providers licensed in your state can evaluate you via video or phone and prescribe these medications legally without ever meeting you face-to-face.

Current DEA Policy Status (2026)

The temporary telehealth prescribing rules for controlled substances remain in effect through the end of 2026, providing continuity while the DEA works on permanent regulations. However, for the non-controlled medications commonly used in BED treatment, no federal restrictions exist—making telehealth a fully viable option nationwide.

State-Specific Telehealth Prescribing Rules

While federal law sets the baseline, individual states add their own requirements. The good news: most states have embraced telehealth prescribing for non-controlled medications. Here’s what you need to know about key states:

States with No In-Person Requirements

California has been particularly progressive, explicitly allowing telehealth exams (including asynchronous online questionnaires) to satisfy the examination requirement before prescribing. A 2025 amendment (AB 1503) further clarified that a ‘good faith exam’ can be conducted entirely via telehealth if it meets the appropriate standard of care.

New York requires no in-person visit for non-controlled medications. While New York implemented stricter rules in May 2025 requiring in-person evaluations for controlled substance prescribing, these regulations explicitly exempt non-controlled medications like those used for BED.

Texas, Delaware, Michigan, Wisconsin, and Florida all permit telehealth prescribing of non-controlled medications without mandatory in-person visits, as long as the provider meets standard-of-care requirements.

States with Periodic In-Person Requirements

A handful of states require periodic in-person follow-up visits for ongoing telehealth care:

Alabama requires that if a patient receives more than four telehealth visits in 12 months for the same condition, they must be seen in-person within that year. However, this requirement can be satisfied by any collaborating provider in the practice, not necessarily the telehealth prescriber.

Georgia asks providers to ‘attempt’ an annual in-person exam for patients receiving ongoing telemedicine care, though initial evaluations can be conducted via telehealth if the technology allows for an examination equivalent to in-person care.

New Hampshire recently updated its laws (effective August 2025) to allow telehealth prescribing of even Schedule II-IV controlled substances, but requires an in-person follow-up at least every 12 months for those medications. For non-controlled BED medications, the rules are more flexible.

Recent State Legislative Changes (2025)

Several states have modernized their telehealth laws in 2025:

• Delaware amended its law (SB 101, July 2025) to explicitly clarify that telemedicine is permitted for medication-assisted treatment of opioid use disorder, further cementing telehealth’s role in behavioral health treatment.
• Wisconsin passed the APRN Modernization Act (August 2025), granting nurse practitioners full practice authority and reinforcing telehealth prescribing pathways.
• Michigan implemented full practice authority for nurse practitioners in 2025, expanding access to telehealth providers.

Who Can Prescribe BED Medications via Telehealth?

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathic medicine licensed in your state can prescribe topiramate and bupropion via telehealth in all 50 states, provided they follow their state’s telehealth standards of care.

Nurse Practitioners (NPs)

The landscape for NP prescribing authority varies significantly by state:

Full Practice Authority States: As of 2025, approximately 34 states plus Washington D.C. grant nurse practitioners full practice authority, meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight. Recent additions include Louisiana, Kansas, Wisconsin, and Michigan.

In these states, an NP working with a telehealth platform like Klarity Health can evaluate you for BED and prescribe appropriate medications entirely independently.

Collaborative Agreement States: States like Florida, Texas, Georgia, and Alabama require NPs to work under a collaborative agreement or supervisory relationship with a physician. This doesn’t typically affect your care experience—the NP conducts your evaluation and manages your treatment—but there’s a physician formally overseeing their practice.

For non-controlled medications like topiramate and bupropion, NPs can prescribe in all states, though the level of autonomy varies. Texas, for example, specifically allows APRNs to prescribe ‘dangerous drugs’ (non-controlled prescription medications) under appropriate physician delegation.

Physician Assistants (PAs)

PAs can also prescribe BED medications in all states, typically under a supervisory agreement with a physician. The specific requirements vary by state, but for non-controlled substances, PA prescribing is widely permitted across the telehealth landscape.

Safety Considerations and Medical Screening

Who Should NOT Use Telehealth for BED Medication?

While telehealth offers convenient access, certain patients require in-person evaluation:

Medical Contraindications:

• Patients with active bulimia or anorexia nervosa should not take bupropion due to significantly increased seizure risk—this is an FDA black box contraindication.
• Those with uncontrolled epilepsy or seizure disorders may not be candidates for either bupropion or topiramate.
• Pregnant patients or those planning pregnancy should avoid topiramate, which carries significant fetal risks including cleft palate and other birth defects.

Clinical Complexity:

• Severe medical instability requiring physical examination
• Complex medication regimens with high interaction risks
• History of severe adverse reactions to similar medications
• Need for controlled substance treatment (like FDA-approved Vyvanse)

What to Expect During Your Telehealth Evaluation

A legitimate telehealth evaluation for BED should be thorough and comprehensive, typically lasting 30-60 minutes for an initial visit. Your provider will:

1. Verify your identity and location (required by many states to ensure proper licensure)
2. Conduct a detailed clinical interview about your eating patterns, including frequency and characteristics of binge episodes
3. Review your complete medical and psychiatric history
4. Screen for contraindications to proposed medications
5. Discuss treatment options, including both medication and therapy
6. Obtain informed consent for off-label medication use (if applicable)
7. Create a follow-up plan for monitoring your response and safety

Reputable platforms like Klarity Health emphasize comprehensive evaluations that meet or exceed in-person standards of care, with transparent pricing and the flexibility to accept both insurance and cash payment.

Red Flags: What to Avoid

Be cautious of telehealth services that:

• Promise prescriptions before completing a proper evaluation
• Conduct superficial 5-minute assessments
• Skip discussion of non-medication treatments
• Sell medications directly without using a licensed pharmacy
• Don’t verify your state of residence or provider licensure
• Fail to provide clear information about provider credentials

Medication-Specific Information

Topiramate (Topamax) for BED

How It Works: Topiramate affects neurotransmitter activity in ways that can reduce food cravings and impulsive eating behaviors.

Typical Dosing: Treatment usually starts at a low dose (25-50 mg) and gradually increases to minimize side effects. Therapeutic doses for BED typically range from 75-200 mg daily.

Important Safety Information:

• Pregnancy Category D: Significant risk of birth defects. Effective contraception is essential for women of childbearing potential.
• Common Side Effects: Cognitive changes (‘word-finding difficulty’), tingling in hands/feet, taste changes (especially with carbonated beverages), weight loss
• Monitoring Needed: Baseline and periodic metabolic panels, kidney function tests, and eye exams (rare but serious glaucoma risk)
• Discontinuation: Should be tapered gradually to prevent seizure risk

Telehealth Considerations: Can be prescribed via telehealth in all states with no special restrictions. Most providers allow up to 90-day supplies with refills.

Bupropion (Wellbutrin) for BED

How It Works: As a norepinephrine-dopamine reuptake inhibitor (NDRI), bupropion can help regulate appetite and reduce the reward-seeking behavior associated with binge eating.

Typical Dosing: Starting dose usually 150 mg once daily of the extended-release formulation, potentially increasing to 300-450 mg daily based on response and tolerability.

Important Safety Information:

• Black Box Warning: Increased risk of suicidal thoughts in patients under 25, especially when starting treatment. Close monitoring is essential.
• Absolute Contraindications: Current or history of bulimia or anorexia nervosa (significantly increased seizure risk), uncontrolled seizure disorder
• Common Side Effects: Dry mouth, insomnia, headache, nausea, increased blood pressure
• Seizure Risk: Dose-dependent; avoid alcohol and be cautious with other medications that lower seizure threshold
• Monitoring Needed: Blood pressure checks, mental health assessment, particularly in the first few months

Telehealth Considerations: Fully available via telehealth nationwide for non-controlled formulations. Providers can prescribe refills for up to 6-12 months depending on state law.

Prescription Monitoring Programs (PMPs)

Many states require prescribers to check the state Prescription Drug Monitoring Program before prescribing controlled substances. However, for non-controlled medications like topiramate and bupropion, PMP checks are generally not legally mandated.

That said, responsible telehealth providers may still review your medication history to:

• Identify potential drug interactions
• Ensure you’re not receiving duplicate prescriptions
• Screen for undisclosed controlled substance use that might affect treatment planning

This is considered good clinical practice rather than a legal requirement for these medications.

Insurance Coverage and Costs

Insurance Coverage for Telehealth

Most private insurance plans and Medicare now cover telehealth visits at parity with in-person visits, thanks to pandemic-era policy changes that have been extended. However, coverage specifics vary:

• Private Insurance: Most plans cover telehealth mental health and psychiatry visits. Check whether your plan requires the provider to be in-network.
• Medicare: Telehealth coverage has been extended through 2026 for mental health services, though some geographic restrictions may apply.
• Medicaid: Coverage varies by state; many states have made pandemic-era telehealth expansions permanent.

Cash-Pay Options

Many telehealth platforms, including Klarity Health, offer transparent cash-pay pricing for patients without insurance or those who prefer not to use their insurance. This can be particularly valuable for:

• Patients with high deductibles
• Those seeking privacy
• Individuals whose insurance doesn’t cover telehealth
• People in states where their insurance network is limited

Cash-pay pricing typically ranges from $99-$199 for initial evaluations and $79-$149 for follow-up visits, depending on the provider and platform.

The Future of Telehealth BED Treatment

Pending DEA Regulations

The DEA is expected to finalize permanent telehealth prescribing rules by the end of 2026. While these regulations will primarily affect controlled substances, the agency has indicated an intent to maintain reasonable access to telehealth while implementing safeguards against abuse.

For non-controlled BED medications, experts anticipate minimal changes—telehealth access should remain robust and potentially expand as the healthcare system continues embracing virtual care.

State-Level Trends

The trend toward full practice authority for nurse practitioners continues, with legislation pending or under discussion in several additional states including Alabama and South Carolina. This expansion of NP independence directly benefits telehealth patients by increasing the pool of qualified providers.

Additionally, states are increasingly adopting interstate licensure compacts (like the Nurse Licensure Compact) that allow providers to practice across state lines more easily, further expanding telehealth access.

Getting Started with Telehealth BED Treatment

Step 1: Research Reputable Providers

Look for telehealth platforms that:

• Employ board-certified psychiatrists, psychiatric NPs, or other qualified mental health prescribers
• Provide transparent information about provider credentials and licensure
• Offer comprehensive evaluations (not just prescription services)
• Have clear policies about follow-up care and emergency situations
• Accept your insurance or offer transparent cash-pay pricing

Klarity Health meets all these criteria, with licensed providers available across multiple states, same-week appointments typically available, and the flexibility to accept both insurance and cash payment.

Step 2: Prepare for Your Evaluation

Before your appointment:

• Document your binge eating patterns (frequency, triggers, duration)
• List all current medications and supplements
• Compile your medical and psychiatric history
• Write down questions about treatment options
• Ensure you have a private, quiet space for your video visit
• Test your internet connection and device camera/microphone

Step 3: Complete Your Initial Visit

During the appointment, be honest and thorough. Your provider needs complete information to make safe, effective treatment recommendations. Discuss:

• Your specific symptoms and how they impact your life
• Previous treatments you’ve tried
• Your goals for treatment
• Any concerns about proposed medications
• Your preference for therapy, medication, or combined treatment

Step 4: Follow Your Treatment Plan

If medication is prescribed:

• Take it exactly as directed
• Attend all scheduled follow-up appointments
• Report any side effects or concerns promptly
• Don’t adjust doses without consulting your provider
• Consider complementary therapy (many telehealth platforms can connect you with therapists who specialize in eating disorders)

Frequently Asked Questions

Q: Is telehealth treatment for BED as effective as in-person care?

A: Research shows that telehealth mental health care, when properly conducted, achieves outcomes comparable to in-person treatment. The key is ensuring comprehensive evaluations and regular follow-up—both of which are standard in reputable telehealth practices.

Q: Will my medication be shipped from the telehealth company?

A: No. Legitimate providers send prescriptions electronically to your local pharmacy (or a licensed mail-order pharmacy of your choice). You should never receive medications directly from a telehealth company’s warehouse.

Q: Can I use telehealth if I live in a rural area?

A: Absolutely. Telehealth specifically benefits patients in underserved areas where specialized eating disorder treatment may not be locally available. As long as you have internet access and your provider is licensed in your state, you can access care.

Q: What happens if the medication doesn’t work or causes side effects?

A: Your provider will schedule regular follow-ups to monitor your response. If a medication isn’t effective or causes intolerable side effects, they can adjust the dose, switch medications, or recommend alternative approaches. This is why ongoing monitoring is essential.

Q: How quickly can I get an appointment?

A: This varies by provider, but many telehealth platforms offer appointments within days or even same-week. Klarity Health, for example, typically has provider availability within 24-48 hours, significantly faster than traditional psychiatry appointments which can have wait times of weeks or months.

Taking the Next Step in Your BED Recovery

If you’re struggling with Binge Eating Disorder, telehealth offers a legitimate, accessible, and effective pathway to treatment. The regulatory environment in 2025-2026 strongly supports remote care for non-controlled medications, and the expansion of provider types (particularly nurse practitioners with full practice authority) means more options than ever.

Remember that medication is just one component of comprehensive BED treatment. The most effective approach typically combines medication management with evidence-based therapy like cognitive behavioral therapy (CBT), nutritional counseling, and support groups.

Ready to explore telehealth treatment for BED? Platforms like Klarity Health connect you with licensed psychiatric providers who specialize in eating disorders, offering comprehensive evaluations, evidence-based treatment plans, and ongoing support—all from the privacy and convenience of your home. With transparent pricing, insurance acceptance, and provider availability across multiple states, taking the first step toward recovery has never been more accessible.

Don’t let Binge Eating Disorder control your life. Effective treatment is available, and telehealth makes it easier to access the care you deserve.

Research Currency Statement

Verified as of: January 4, 2026

Federal Regulations:

• DEA telehealth flexibilities for controlled substances extended through December 31, 2026 (fourth extension)
• Non-controlled medications remain unrestricted for telehealth prescribing (never subject to Ryan Haight Act requirements)

State Law Review:

• Researched 10+ key states with latest legislative updates as of late 2025
• 80%+ of sources from 2025 or verified current through 2025 references
• Flagged items requiring monitoring: Alabama and South Carolina NP scope legislation (pending confirmation of final status), DEA’s pending permanent telehealth rule (expected by end of 2026)

Citations

1. U.S. Department of Health and Human Services. ‘HHS and DEA Extend Telemedicine Prescribing Flexibilities Through 2026.’ Press Release, January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog, August 2025. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ Updated November-December 2025. https://www.cchpca.org/topic/online-prescribing/

4. National Law Review. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ 2025. https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

5. Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs – Updated 2025.’ Blog post, 2025. https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12